GOLDMAN SACHS GROUP INC - PHARMATHENE INC ownership

PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 34 filers reported holding PHARMATHENE INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PHARMATHENE INC
ValueSharesWeighting
Q1 2017$199,000
+7.6%
245,365
+330.5%
0.00%
Q4 2016$185,000
+277.6%
56,991
+240.3%
0.00%
Q3 2016$49,000
+53.1%
16,746
-1.5%
0.00%
Q4 2015$32,000
+113.3%
17,004
+52.4%
0.00%
Q3 2015$15,000
-37.5%
11,157
-16.0%
0.00%
Q2 2015$24,000
+9.1%
13,287
-0.9%
0.00%
Q1 2015$22,000
-18.5%
13,409
-8.8%
0.00%
Q4 2014$27,000
-80.3%
14,703
-82.9%
0.00%
Q2 2013$137,000
+226.2%
86,024
+141.4%
0.00%
Q3 2012$42,000
-40.0%
35,632
-28.8%
0.00%
Q2 2012$70,000
+159.3%
50,053
+229.4%
0.00%
Q1 2012$27,00015,1930.00%
Other shareholders
PHARMATHENE INC shareholders Q3 2015
NameSharesValueWeighting ↓
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 7,981,035$15,084,0003.59%
PERKINS CAPITAL MANAGEMENT INC 953,800$1,803,0002.26%
Nantahala Capital Management 3,251,838$6,390,0000.66%
Hudson Bay Capital Management LP 3,133,394$5,922,0000.28%
Visium Asset Management, LP 1,800,000$3,402,0000.06%
Burt Wealth Advisors 30,000$57,0000.05%
ONTARIO TEACHERS PENSION PLAN BOARD 1,520,451$2,874,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 594,444$1,124,0000.02%
Acrospire Investment Management LLC 6,000$11,0000.01%
TFS CAPITAL LLC 17,741$34,0000.01%
View complete list of PHARMATHENE INC shareholders